Delivery Order SPE2DB20D2104-SPE2DB25FMGXF
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Otezla 30 mg tablets, a specialty medication. The firm-fixed-price contract has a ceiling value of $1,312.62 and a period of performance through October 2024. The contract is not designated with any set-aside requirements, indicating open competition. It is associated with a larger Indefinite Delivery Contract...
This is a $7,145.70 Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a period of performance through June 28, 2024 and is a Firm Fixed Price agreement. This award is not associated with a set-aside program. It is a child contract under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,011.78 firm fixed-price delivery order is for the supply of Otezla 30 mg tablets, a specialty medication. The contract has an ultimate completion date of August 1, 2022. This award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Otezla 30 mg tablets, a specialty pharmaceutical product, with a potential value of $2,772.14 and a completion date of February 13, 2024. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,841.75, is for the supply of Otezla 30 mg tablets. The award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Otezla 30 mg tablets. The $1,406.30 firm-fixed-price contract does not have a set-aside designation, indicating open competition. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,521,682 units of the medication Otezla 30 mg Tablet 60s. The contract has a ceiling value of $4,480.14 and is a firm fixed-price delivery order with a period of performance through August 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,089.35, is for the delivery of 4567027116 Otezla 30 mg tablets. The contract has an ultimate completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,767.67 firm fixed-price contract is for the delivery of Otezla 30 mg tablets. It is not designated as a set-aside contract. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,933.52 firm fixed-price contract is for the supply of Otezla 30 mg tablets, a prescription medication used to treat certain medical conditions. The contract has an ultimate completion date of March 20, 2024. While the original solicitation is not provided, the award indicates that this is a delivery order...